Radiology has been in the regulatory crosshairs for almost six years, ever since the DRA eliminated billions in reimbursements for imaging—and the profession can expect the trend to continue, if it doesn’t invest in research now. That’s the contention of Christoph I. Lee, MD, a UCLA Robert Wood Johnson Foundation clinical scholar, and Howard P.

I know many radiologists who are trying—desperately, in some cases—to see how their group practices can fit neatly within what will eventually be defined as accountable-care organizations (ACOs). I say eventually because I have seen no true outline of how an ACO will work in real time, in the real world, or in any organization with which I have

U.S. consumer group Public Citizen is alleging that researchers with ties to Eli Lilly and Co. withheld from the Journal of the American Medical Association (JAMA) important information that should have been included in a study of Amyvid (florbetapir), an imaging agent for Alzheimer’s disease. Published on January 19, the study assessed the

The American College of Radiology (ACR) has launched the Dose Index Registry (DIR), a vehicle to which medical imaging facilities can submit anonymized dose information for all CT exams performed and compare their dose indices to those of other facilities of similar size or geographic area as well as to national benchmarks. Participating facilities

INFINITT North America, a provider of image and information management solutions for healthcare, yesterday announced that its INFINITT G3 RIS/PACS system has been tested and certified as meeting the Modular EHR requirements for ambulatory settings, in accordance with ONC-ATCB certification criteria. Certification by an ATCB (Authorized Testing and

Few families without health insurance have the financial assets to pay potential hospital bills, reveals a new report released today by the U.S. Department of Health and Human Services (HHS). On average, the report says, uninsured families can only afford to pay in full for approximately 12% of hospital stays they may experience--bills that account

Susceptibility-weighted imaging (SWI) is a powerful tool for characterizing infarctions in patients earlier and directing more prompt treatment, according to a study presented last week at the annual meeting of the American Roentgen Ray Society (ARRS) in Chicago.

Ampronix Incorporated last week announced that its Modalixx G202MP autosync modality LCD display has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).